ITEMS IN AFP WITH KEYWORD:
Dec 15, 2012 Issue
ACP Releases Best Practice Advice on Colorectal Cancer Screening [Practice Guidelines]
The American College of Physicians (ACP) recently reviewed guidelines on colorectal cancer screening available from the American Cancer Society/U.S. Multi-Society Task Force on Colorectal Cancer/American College of Radiology, Institute for Clinical Systems Improvement, U.S. Preventive Services Task ...
Apr 15, 2010 Issue
Screening for Colorectal Cancer: Recommendation Statement [U.S. Preventive Services Task Force]
The U.S. Preventive Services Task Force (USPSTF) recommends screening for colorectal cancer in adults using fecal occult blood test (FOBT), sigmoidoscopy, or colonoscopy, beginning at 50 years of age and continuing until 75 years of age. The risks and benefits of these screening methods vary.
Case study: N.P., a 51-year-old man, comes to your office because one of his friends was recently diagnosed with colorectal cancer. He is wondering whether he should be screened too.
The American College of Gastroenterology (ACG) updated its recommendations on screening for colorectal cancer in 2008, and continues to support colonoscopy in average-risk patients every 10 years based on the evidence of effectiveness, cost-effectiveness, and patient acceptance.
Feb 15, 2009 Issue
Routine Aspirin or Nonsteroidal Anti-inflammatory Drugs for the Primary Prevention of Colorectal Cancer [Putting Prevention into Practice]
Case study: B.L., a 37-year-old Asian man, comes to your office for a physical examination. He mentions that he started taking a daily aspirin because he heard that it would reduce his risk of heart attack and colorectal cancer.
Colorectal cancer causes significant morbidity and mortality in the United States. The incidence of colorectal cancer can be reduced with increasing efforts directed at mass screening of average-risk adults 50 years and older. Currently, fecal occult blood test and flexible sigmoidoscopy have the hi...
This article describes a joint update of guidelines by the American Cancer Society and the U.S. Multi-Society Task Force on Colorectal Cancer delineating evidence-based surveillance recommendations for patients after polypectomy and colorectal cancer resection. Although there are some qualifying con...
Jul 1, 2007 Issue
Routine Aspirin or Nonsteroidal Anti-inflammatory Drugs for the Primary Prevention of Colorectal Cancer: Recommendation Statement [U.S. Preventive Services Task Force]
This statement summarizes the U.S. Preventive Services Task Force (USPSTF) recommendations on routine aspirin or non-steroidal anti-inflammatory drugs (NSAIDs) for the primary prevention of colorectal cancer and the supporting scientific evidence.
Jun 1, 2007 Issue
Fecal Occult Blood Tests Reduce Colorectal Cancer Mortality [Cochrane for Clinicians]
Fecal occult blood testing reduces colorectal cancer mortality by 16 percent. Annual testing and rehydration of samples increases testing sensitivity but also increases the number of false-positive results.
Sep 15, 2006 Issue
CDC Recommends Increased Awareness for Colorectal Screening [Practice Guidelines]
The CDC recommends continued measures to encourage screening to reduce mortality rates from colorectal cancer. The Centers for Disease Control and Prevention (CDC) has compared data from the 2002 and 2004 Behavioral Risk Factor Surveillance System (BRFSS) surveys to determine the number of persons r...